• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制蛋白p16INK4a

The tumor suppressor protein p16INK4a.

作者信息

Serrano M

机构信息

Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain.

出版信息

Exp Cell Res. 1997 Nov 25;237(1):7-13. doi: 10.1006/excr.1997.3824.

DOI:10.1006/excr.1997.3824
PMID:9417860
Abstract

The tumor suppressor protein p16INK4a (inhibitor of CDK4) is one of the most direct links between cell-cycle control and cancer. The p16INK4a gene is frequently inactivated in human tumors, and inheritance of mutant alleles results in susceptibility to several types of cancer. p16INK4a is part of a cell-cycle regulatory pathway that converges in the tumor suppressor protein Rb. The mechanisms that regulate p16INK4a are starting to be characterized.

摘要

肿瘤抑制蛋白p16INK4a(细胞周期蛋白依赖性激酶4抑制剂)是细胞周期调控与癌症之间最直接的联系之一。p16INK4a基因在人类肿瘤中经常失活,突变等位基因的遗传会导致对多种癌症的易感性。p16INK4a是细胞周期调节途径的一部分,该途径在肿瘤抑制蛋白Rb中汇聚。调节p16INK4a的机制正开始得到阐明。

相似文献

1
The tumor suppressor protein p16INK4a.肿瘤抑制蛋白p16INK4a
Exp Cell Res. 1997 Nov 25;237(1):7-13. doi: 10.1006/excr.1997.3824.
2
Cell cycle control and cancer.细胞周期调控与癌症。
Harvey Lect. 2000;96:73-92.
3
The Pezcoller lecture: cancer cell cycles revisited.佩兹科勒讲座:重探癌细胞周期
Cancer Res. 2000 Jul 15;60(14):3689-95.
4
Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.唾液腺腺样囊性癌中RB通路(Rb-p16INK4A-细胞周期蛋白D1)的罕见改变
Anticancer Res. 2000 May-Jun;20(3B):2169-75.
5
The physiology of p16(INK4A)-mediated G1 proliferative arrest.p16(INK4A)介导的G1期增殖停滞的生理学
Cell Biochem Biophys. 2000;33(2):189-97. doi: 10.1385/CBB:33:2:189.
6
[Alternative protein p19ARF: a genuine tumor suppressor gene].[替代蛋白p19ARF:一种真正的肿瘤抑制基因]
Bull Cancer. 1998 Apr;85(4):304-6.
7
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.人甲状腺癌细胞系和原发性甲状腺癌中细胞周期蛋白依赖性激酶抑制剂p15INK4b和p16INK4a的遗传和表观遗传改变。
Cancer. 1998 Nov 15;83(10):2185-93.
8
Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.过表达的突变型E2F1E132可解除小鼠黑素细胞中的细胞周期限制,但缺失p16INK4A或p21WAF1/CIP1则不能。
Oncogene. 1998 May 14;16(19):2489-501. doi: 10.1038/sj.onc.1201773.
9
P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.P16Ink4a在肺癌细胞中的肿瘤抑制功能涉及通过Cip/Kip蛋白重新分布来抑制细胞周期蛋白依赖性激酶2。
Cell Growth Differ. 2000 Oct;11(10):507-15.
10
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.p16INK4a/p16α和p19ARF/p16β的表达在非小细胞肺癌中经常发生改变,且与p53过表达相关。
Oncogene. 1998 Nov 26;17(21):2779-85. doi: 10.1038/sj.onc.1202501.

引用本文的文献

1
Addressing osteoblast senescence: Molecular pathways and the frontier of anti-ageing treatments.应对成骨细胞衰老:分子途径与抗衰老治疗前沿
Clin Transl Med. 2025 Jul;15(7):e70417. doi: 10.1002/ctm2.70417.
2
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.处于十字路口的胶质母细胞瘤:当前的认识与未来的治疗前景
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4.
3
Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment.
卵巢交界性肿瘤中的分子生物标志物:迈向个性化治疗与预后评估
Cancers (Basel). 2025 Feb 6;17(3):545. doi: 10.3390/cancers17030545.
4
[Immunohistochemical examinations in malignant melanoma : Fundamentals and special aspects].[恶性黑色素瘤的免疫组织化学检查:基础与特殊方面]
Dermatologie (Heidelb). 2024 Dec;75(12):947-966. doi: 10.1007/s00105-024-05424-6. Epub 2024 Nov 25.
5
Multiple outcomes of the germline p16 mutation affecting senescence and immunity in human skin.种系p16突变对人类皮肤衰老和免疫的多种影响
Aging Cell. 2025 Feb;24(2):e14373. doi: 10.1111/acel.14373. Epub 2024 Oct 17.
6
PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.PR55α 调控的蛋白磷酸酶 2A 抑制 p16 的表达并阻断 γ 射线诱导的细胞衰老。
Aging (Albany NY). 2024 Mar 4;16(5):4116-4137. doi: 10.18632/aging.205619.
7
p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker?p16在喉鳞状细胞癌中的表达:一个替代指标还是独立的预后标志物?
Pathogens. 2024 Jan 24;13(2):100. doi: 10.3390/pathogens13020100.
8
Conversion of senescent cartilage into a pro-chondrogenic microenvironment with antibody-functionalized copper sulfate nanoparticles for efficient osteoarthritis therapy.用抗体功能化的硫酸铜纳米粒子将衰老的软骨转化为促软骨形成的微环境,用于高效的骨关节炎治疗。
J Nanobiotechnology. 2023 Aug 8;21(1):258. doi: 10.1186/s12951-023-02036-5.
9
Developmental Expression of the Cell Cycle Regulator p16 in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?细胞周期调控因子 p16 在视网膜神经胶质细胞中的发育表达:未成熟眼神经胶质细胞的新标志物?
J Histochem Cytochem. 2023 Jun;71(6):301-320. doi: 10.1369/00221554231184286. Epub 2023 Jun 23.
10
Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging.对基因独立的衰老表型进行孟德尔随机化分析,确定脂蛋白A和血管细胞黏附分子1为人类衰老的生物学靶点。
Nat Aging. 2022 Jan;2(1):19-30. doi: 10.1038/s43587-021-00159-8. Epub 2022 Jan 20.